Bupivacaine Hydrochloride Structure (Bupivacaine Hydrochloride Injection Usp Multiple D 1)
Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 0143-9329
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 0143-9329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
9328-01 (Bupivacaine Hydrochloride Injection Usp Multiple D 2)
This appears to be a prescription label for a medication called Bupivacaine HCl. The label indicates that it is a multi-dose vial with a volume of 50 miles (milliliters). It is intended for use as an anesthetic but is specifically not suitable for caudal, epidural, or spinal anesthesia. It also notes that there are no preservatives added.*
9328-10 (Bupivacaine Hydrochloride Injection Usp Multiple D 3)
PLB205-WES/2 is a multiple-dose vial of Bupivacaine HCl injection, used as a local anesthetic in surgeries or medical procedures. It contains 125 mg of Bupivacaine HCl per 50 mL of solution. The solution is preserved with an antiseptic preservative but is not suitable for caudal, epidural, or spinal anesthesia. It is sterilized, nonpyrogenic and must be stored between 20-25°C with excursions permitted between 15-30°C. The product is manufactured by HIKMA Pharmaceuticals (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. The package insert contains information about the usual dosage. To use, the seal along the dotted line must be cut.*
9329-01 (Bupivacaine Hydrochloride Injection Usp Multiple D 4)
This is a medication description for a 50 mL multiple-dose vial of Bupivacaine HCI Injection. The medication is not recommended for use in caudal, epidural, or spinal anesthesia, and includes a preservative. However, no further information is available about the usual dosage or administration of the medication.*
9329-10 (Bupivacaine Hydrochloride Injection Usp Multiple D 5)
PLB204-WES/3 is bupivacaine HCI injection prescribed for nerve blocks. The solution contains 5 mg/mL, and each 50 mL vial contains 250 mg of the medicine. A preservative has been added, and the solution is not suitable for caudal, epidural, or spinal anesthesia. Each mL contains 5 mg of bupivacaine HCI, USP and various other ingredients, including methylparaben. The usual dosage can be found in the package insert. The solution is sterile, nonpyrogenic, and is manufactured by HIKMA FARMACEUTICA (PORTUGAL), SA and distributed by Hikma Pharmaceuticals USA, Berkeley Heights, NJ. The storage temperature for this medicine is 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit), with excursions permitted between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit).*
Representative Serialization Image (Bupivacaine Hydrochloride Injection Usp Multiple D 6)
This is a product with a Global Trade Item Number (GTIN) of 00301439329107. It has a serial number (SN) of 12345678901234 and an expiration date (EXP) of 12/2099. The LOT number (L0T) is 0000000.0.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
